Z. Zhou et al. / Inorganica Chimica Acta 392 (2012) 345–353
351
2.13 mmol) yield. mp 200–201 °C, IR (KBr; cmꢁ1):
m
3362, 3019,
4. Experimental
1601, 1583, 1519, 1469, 1397, 1375, 1247, 1078, 741, 621. 1H
NMR (CDCl3, 400 MHz, TMS):
d 7.67 (d, J = 7.46 Hz, 1H),
4.1. General consideration
7.38ꢁ7.17 (m, 14H), 6.79 (s, 1H), 6.09 (s, 1H), 4.02 (s, 3H), 2.28
(s, 3H). 13C NMR (CDCl3, 100 MHz, TMS): d 21.27, 33.27, 50.10,
109.60, 112.63, 118.84, 123.06, 123.28, 125.84, 126.27, 126.91,
128.37, 129.62, 132.86, 133.12, 135.86, 140.52, 143.77, 152.19,
154.62. Anal. Calc. for C28H24N2O: C, 83.14; H, 5.98; N, 6.93. Found:
C, 83.05; H, 6.04; N, 6.79%.
All manipulations of air and/or moisture-sensitive compounds
were carried out under an atmosphere of nitrogen using standard
Schlenk techniques. THF was refluxed over sodium-benzophenone
and distilled under nitrogen prior to use. 3-Benzhydryl-2-hydroxy-
5-methylbenzaldehyde was prepared according to the literature
method [38]. All aniline derivatives were purchased and used as
the obtained. 1H and 13C NMR spectra were recorded on a Bruker
DMX400 MHz instrument at ambient temperature using TMS as
an internal standard. Absorption spectra were determined on a
SHIMADZU UV-1601PC UV–Vis Spectrophotometer. IR spectra
were recorded on a Perkin–Elmer System 2000 FT-IR spectrometer
using a KBr disc in the range of 400–4000 cmꢁ1. Elemental analyses
were performed on a Flash EA 1112 microanalyzer. The steady-
state fluorescent spectra were measured on an F4500-FL fluores-
cence spectrophotometer; fluorescence lifetimes were obtained
using the time-correlated single-photon counting technique (Edin-
burgh Analytical Instruments F900 fluorescence spectrofluorime-
ter). Thin films of the samples were prepared on quartz slides
4.2.3. 2-Benzhydryl-6-(1-ethyl-benzoimidazol-2-yl)-4-methylphenol
(L3)
Using the above procedure as for the synthesis of L2, but using
N-ethyl-2-nitrobenzenamine (1.31 g, 7.92 mmol), 3-benzhydryl-2-
hydroxy-5-methylbenzaldehyde (2.39 g, 7.92 mmol), and sodium
hydrosulfite (7.18 g, 41.2 mmol) was added, respectively. L3 was
as a yellow powder in 30.2% (0.85 g, 2.03 mmol) yield. mp 155–
156 °C, IR (KBr; cmꢁ1):
m 3375, 3022, 1599, 1579, 1493, 1468,
1398, 1378, 1246, 1076, 741, 696. 1H NMR (CDCl3, 400 MHz,
TMS): d 7.66 (d, J = 7.38 Hz, 1H), 7.42 (d, J = 7.50 Hz, 1H), 7.32–
7.09 (m, 11H), 6.80 (s, 1H), 6.50 (s, 1H), 6.09 (s, 1H), 5.67 (s, 1H),
4.48-4.43 (q, 2H), 2.28 (s, 3H), 1.64 (t, J = 7.2 Hz, 3H). 13C NMR
(CDCl3, 100 MHz, TMS): d 15.34, 21.14, 21.35, 40.72, 50.15, 51.24,
109.74, 112.64, 118.95, 123.06, 123.27, 125.20, 126.26, 126.99,
128.37, 128.63, 129.48, 129.51, 129.63, 130.97, 132.99, 133.12,
135.00, 140.69, 142.89, 143.81, 151.60, 154.65. Anal. Calc. for
(1 cm) through spin-coating. Fluorescence quantum yields (UF
)
were calculated according to the comparative method, using
anthracene in methanol (UF = 0.29) as a standard [27,39–41].
R
2
IF;x
IF;s
ð
v
v
Þd
v
v
ꢀ ð1 ꢁ 10ꢁAsÞ ꢀ ðnxÞ
UF;x
¼
UF;s
R
2
ð
Þd
ꢀ ð1 ꢁ 10ꢁAxÞ ꢀ ðnsÞ
C29H26N2O: C, 83.22; H, 6.26; N, 6.69. Found: C, 83.15; H, 6.33;
N, 6.35%.
R
where UF,s is the quantum yield of standard, integrals IF,x
(v
)dv and
R
IF,s
(v
)dv are the areas under curves of the sample and standard,
) and IF,s
sample and the standard, respectively. Ax and As are absorptions
of the sample and standard, nx and ns are refractive indices of the
solvents.
IF,x
(v
(v
) are fluorescence intensities at wavelength for the
4.2.4. 2-Benzhydryl-6-(1-isopropyl-benzoimidazol-2-yl)-4-
methylphenol (L4)
Using the above procedure, but using N-isopropyl-2-nitroben-
zenamine (2.33 g, 12.9 mmol) was used instead of N-ethyl-2-
nitrobenzenamine, reaction with 3-benzhydryl-2-hydroxy-5-
methylbenzaldehyde (3.90 g, 12.9 mmol) and sodium hydrosulfite
(11.7 g, 67.2 mmol). The product was obtained as a yellow powder
in 13.6% (0.76 g, 1.76 mmol) yield. mp 158–159 °C, IR (KBr; cmꢁ1):
4.2. Preparation of ligands
4.2.1. 6-Benzhydryl-4-methyl-2-(benzoimidazol-2-yl)phenol (L1)
A modified synthetic procedure for the ortho-nitroaniline deriv-
atives (1.21 g, 11.2 mmol) was employed: DMF/H2O = 4:1
(80 mL:20 mL), sodium hydrosulfite (10.1 g, 58.3 mmol), 3-benz-
hydryl-2-hyd roxy-5-methylbenzaldehyde (3.38 g, 11.2 mmol)
were combined under nitrogen. The reaction mixture was refluxed
for 5 h. The solvent was then removed in vacuo, and the resultant
residue was dissolved with dichloromethane. The combined organ-
ic extracts were dried and purified on an alumina column using
petroleum ether/ethyl acetate (v/v = 25:1) as the eluent to obtain
m
3341, 3054, 2910, 1599, 1493, 1441, 1391, 1367, 1244, 1069, 740,
699. 1H NMR (CDCl3, 400 MHz, TMS): d 7.72 (d, J = 7.50 Hz, 1H),
7.66 (d, J = 7.52 Hz, 1H), 7.34–7.13 (m, 11H), 6.83 (s, 1H), 6.53 (s,
1H), 6.12 (s, 1H), 5.70 (s, 1H), 5.22 (m, 1H), 2.30 (s, 3H), 1.75 (d,
J = 6.88 Hz, 6H). 13C NMR (CDCl3, 100 MHz, TMS): d 21.14, 21.28,
21.60, 50.10, 51.24, 112.86, 113.32, 119.52, 122.65, 126.22,
126.29, 126.72, 127.24, 128.37, 128.62, 129.51, 129.64, 130.97,
133.01, 133.15, 142.13, 142.89, 143.72, 151.78, 153.86. Anal. Calc.
for C30H28N2O: C, 83.30; H, 6.52; N, 6.48. Found: C, 83.24; H,
6.67; N, 6.30%.
the target compound as
a white powder in 16.7% (0.76 g,
1.87 mmol) yield. mp 241ꢁ242 °C, IR (KBr; cmꢁ1):
m 3382, 3025,
2921, 1628, 1596, 1525, 1448, 1383, 1252, 1073, 739, 690. 1H
NMR (CDCl3, 400 MHz, TMS): d 7.53 (m, 2H), 7.31–7.16 (m, 13H),
6.77 (s, 1H), 6.08 (s, 1H), 2.24 (s, 3H). 13C NMR (CDCl3, 100 MHz,
4.2.5. 2-Benzhydryl-6-(1-benzyl-benzoimidazol-2-yl)-4-methylphenol
(L5)
TMS):
d 14.34, 20.94, 49.89, 60.65, 111.45, 123.35, 123.44,
Following the same procedure described for the formation of L4,
treatment of N-benzyl-2-nitrobenzenamine (1.70 g, 7.47 mmol),
3-benzhydryl-2-hydroxy-5-methylbenzaldehyde (2.26 g, 7.47
mmol), and sodium hydrosulfite (6.78 g, 39.0 mmol) gave L5
126.37, 128.42, 129.62, 132.94, 133.67, 143.59, 151.61, 154.60.
Anal. Calc. for C27H22N2O: C, 83.05; H, 5.68; N, 7.17. Found: C,
82.97; H, 5.72; N, 7.02%.
(0.52 g, 2.28 mmol, 14.5%). mp 196–197 °C, IR (KBr; cmꢁ1):
m
4.2.2. 2-Benzhydryl-4-methyl-6-(1-methyl-benzoimidazol-2-
yl)phenol (L2)
3026, 2913, 1605, 1496, 1444, 1397, 1250, 1155, 740, 691. 1H
NMR (CDCl3, 400 MHz, TMS): d 7.71 (d, J = 7.71 Hz, 1H), 7.38–
7.14 (m, 18H), 7.10 (s, 1H), 6.74 (s, 1H), 6.08 (s, 1H), 5.60 (s, 2H),
2.04 (s, 3H). 13C NMR (CDCl3, 100 MHz, TMS): d 20.97, 35.16,
50.10, 110.16, 112.19, 119.04, 123.39, 123.66, 125.73, 125.99,
126.27, 127.08, 128.10, 128.36, ‘129.40, 132.84, 133.27, 135.94,
136.39, 140.82, 143.76, 152.64, 154.53. Anal. Calc. for C34H28N2O:
C, 84.97; H, 5.87; N, 5.83. Found: C, 84.68; H, 5.94; N, 5.79%.
Using the same procedure as for the synthesis of L1, but using
a solution of N-methyl-2-nitrobenzenamine (1.46 g, 9.63 mmol)
and 3-benzhydryl-2-hydroxy-5-methylbenzaldehyde (2.91 g, 9.63
mmol) in DMF/H2O = 4:1 (80 mL:20 mL) was treated with about
5.2 equivalents of sodium hydrosulfite (8.73 g, 50.2 mmol) under
nitrogen. L2 was obtained as a yellow powder in 22.1% (0.86 g,